Andere Kunden interessierten sich auch für
![Registration Process of Generic Budesonide DPI as per USFDA Guidelines]( "Registration Process of Generic Budesonide DPI as per USFDA Guidelines")
Registration Process of Generic Budesonide DPI as per USFDA Guidelines44,99 €![A Guidebook to Generic Drug registration in India]( "A Guidebook to Generic Drug registration in India")
A Guidebook to Generic Drug registration in India51,99 €![International Regulatory Approaches to Bioequivalence of Generic OIDPs]( "International Regulatory Approaches to Bioequivalence of Generic OIDPs")
International Regulatory Approaches to Bioequivalence of Generic OIDPs36,99 €![Barriers regulatory agencies face for approval of Parkinson's and Alzheimer's drugs in United States and Europe, and possible ways to overcome them]( "Barriers regulatory agencies face for approval of Parkinson's and Alzheimer's drugs in United States and Europe, and possible ways to overcome them")
Barriers regulatory agencies face for approval of Parkinson's and Alzheimer's drugs in United States and Europe, and possible ways to overcome them27,95 €![CRC Handbook of Sample Size Guidelines for Clinical Trials]( "CRC Handbook of Sample Size Guidelines for Clinical Trials")
CRC Handbook of Sample Size Guidelines for Clinical Trials267,99 €![Toxicological Risk Assessment of A South Asian Herbal Formulation]( "Toxicological Risk Assessment of A South Asian Herbal Formulation")
Toxicological Risk Assessment of A South Asian Herbal Formulation26,99 €![A book of pharmacognosy practical guidelines]( "A book of pharmacognosy practical guidelines")
A book of pharmacognosy practical guidelines29,99 €
Document from the year 2022 in the subject Pharmacology, Andhra University (A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam), course: Pharmaceutical Regulatory Affairs, language: English, abstract: This publication examines the regulatory guidelines for registration and submission criteria in South Africa. South African Health Products Regulatory Authority (SAHPRA) is the entity of the national department of health (NDoH) launched in February 2017. It replaced the former Medicines Control Council (MCC) as well as Directorate of Radiation Control (DRC) that regulated medical devices in-vitro diagnostic tests and devices, radiation-emitting products and devices used in health care and industry. Due to several drawbacks of MCC such as becoming dependent on external expertise, it eventually lead to lack of effective performance management contracts and unsustainable mechanism for submission of evaluation reports, SAHPRA is established. An application for registration of medicines should be submitted for evaluation and approval through SAHPRA guidelines which are applicable to human medicines including biological and complimentary medicines. So SAHPRA adopted EU variation guidelines for quality and bio equivalence requirements for new registration and variations that are submitted by applicant in eCTD format established by the International Council for Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Submission of applications are done by following South Africa eCTD validation criteria in module 1 of regional information provided by South Africa.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.